| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 124 |
| 1 | SOTORASIB | 98 |
| 2 | PEMETREXED DISODIUM | 88 |
| 3 | PEMETREXED | 70 |
| 4 | PACLITAXEL | 63 |
| 5 | BEVACIZUMAB | 60 |
| 6 | CRIZOTINIB | 52 |
| 7 | PACLITAXEL (AIBUMIN-BOUND) | 49 |
| 8 | METHOTREXATE SODIUM | 46 |
| 9 | OSIMERTINIB | 43 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SOTORASIB | 98 | 0.0282 |
| 1 | AMIVANTAMAB-VMJW | 35 | 0.0098 |
| 2 | CERITINIB | 17 | 0.0071 |
| 3 | BRIGATINIB | 21 | 0.0057 |
| 4 | CAPMATINIB | 12 | 0.0051 |
| 5 | LORLATINIB | 37 | 0.0050 |
| 6 | CRIZOTINIB | 52 | 0.0041 |
| 7 | ALDESLEUKIN | 4 | 0.0032 |
| 8 | ERLOTINIB HYDROCHLORIDE | 39 | 0.0031 |
| 9 | PEMETREXED DISODIUM | 88 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 186 |
| 1 | Platinum-based Drug [EPC] | 149 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 108 |
| 3 | Corticosteroid [EPC] | 92 |
| 4 | Microtubule Inhibitor [EPC] | 81 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 76 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 74 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 63 |
| 8 | Proton Pump Inhibitor [EPC] | 45 |
| 9 | Benzodiazepine [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 4 | 0.0032 |
| 1 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 76 | 0.0008 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 4 | Platinum-based Drug [EPC] | 149 | 0.0005 |
| 5 | Microtubule Inhibitor [EPC] | 81 | 0.0005 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 6 | 0.0004 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 63 | 0.0003 |
| 8 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Kinase Inhibitor [EPC] | 186 | 0.0003 |